CO6361893A2 - Método y composición para modulación del color - Google Patents

Método y composición para modulación del color

Info

Publication number
CO6361893A2
CO6361893A2 CO11075524A CO11075524A CO6361893A2 CO 6361893 A2 CO6361893 A2 CO 6361893A2 CO 11075524 A CO11075524 A CO 11075524A CO 11075524 A CO11075524 A CO 11075524A CO 6361893 A2 CO6361893 A2 CO 6361893A2
Authority
CO
Colombia
Prior art keywords
composition
color modulation
skin color
modulation
melanosomes
Prior art date
Application number
CO11075524A
Other languages
English (en)
Inventor
John Steven Bajor
Carol Annette Bosko
Jorge Louie Cardenas
Diana Jean Drennan
Diana Marrero
Sheila Alves Rocha
Original Assignee
Unilever Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unilever Nv filed Critical Unilever Nv
Publication of CO6361893A2 publication Critical patent/CO6361893A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42—Amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782—Enzyme inhibitors; Enzyme antagonists

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

La invención está dirigida a un método y composición adecuada para la modulación del color de la piel. Particularmente, se reduce la acción de la D-dopacromo tautomerasa en la melanogénesis y/o la transferencia de melanina desde los melanosomas en queratinocitos, produciendo de esta forma un cambio en el color de la piel.
CO11075524A 2008-12-24 2011-06-16 Método y composición para modulación del color CO6361893A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12/343,817 US20100158829A1 (en) 2008-12-24 2008-12-24 Method and Composition for Color Modulation

Publications (1)

Publication Number Publication Date
CO6361893A2 true CO6361893A2 (es) 2012-01-20

Family

ID=42224133

Family Applications (1)

Application Number Title Priority Date Filing Date
CO11075524A CO6361893A2 (es) 2008-12-24 2011-06-16 Método y composición para modulación del color

Country Status (6)

Country Link
US (1) US20100158829A1 (es)
EP (1) EP2367522A2 (es)
JP (1) JP2012513967A (es)
CO (1) CO6361893A2 (es)
MX (1) MX2011006915A (es)
WO (1) WO2010072805A2 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102011009112A1 (de) 2011-01-21 2012-07-26 Merck Patent Gmbh Chromen-4-on-Derivate
EP3021818A1 (en) * 2013-07-15 2016-05-25 The Procter & Gamble Company Applied films for smoothing wrinkles and skin texture imperfections

Family Cites Families (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2895877A (en) * 1956-07-30 1959-07-21 Mcneilab Inc Composition and method for relieving spasticity
US3272713A (en) * 1961-07-26 1966-09-13 Univ Minnesota Actinic radiation protection by compositions comprising quinones and carbonyl containing compounds
US3277165A (en) * 1962-02-08 1966-10-04 Merck & Co Inc Fumaramic acid derivatives
US4206229A (en) * 1978-08-17 1980-06-03 Givaudan Corporation Preservation of aqueous systems with α-bromo-β-aminocrotononitrile
JPS6061513A (ja) * 1983-09-14 1985-04-09 Sansho Seiyaku Kk 化粧料
IL83775A (en) * 1987-09-04 1991-12-15 Dexter Chemical Corp Amino acid esters and amides of fumaric acid and pharmaceutical compositions containing them for use in the treatment of psoriasis
JP2618658B2 (ja) * 1987-10-15 1997-06-11 株式会社三光生物科学研究所 皮膚化粧料
US5173289A (en) * 1988-01-20 1992-12-22 Centre International De Recherches Dermatologiques (C.I.R.D.) Aromatic esters and thioesters, a process for their preparation and their use in human or veterinary medicine and in cosmetic compositions
CA2020887A1 (en) * 1989-07-28 1991-01-29 Michael Klaus Aromatic carboxylic amides
JP2593714B2 (ja) * 1989-09-20 1997-03-26 株式会社 林原生物化学研究所 色白剤
FR2661829B1 (fr) * 1990-05-14 1994-10-21 Thorel Jean Noel Nouvelles compositions hydratantes et protectrices pour le bronzage notamment sans soleil.
JPH05247001A (ja) * 1991-12-05 1993-09-24 Ishihara Sangyo Kaisha Ltd 置換ベンゾイルウレア誘導体又はその塩、それらの製造方法及びそれらを含有する抗癌剤
DE4215501C2 (de) * 1992-05-12 1998-10-22 Kao Corp Haut- und Haarpflegemittel
US6774227B1 (en) * 1993-05-17 2004-08-10 Cytokine Pharmasciences, Inc. Therapeutic uses of factors which inhibit or neutralize MIF activity
US6080407A (en) * 1993-05-17 2000-06-27 The Picower Institute For Medical Research Diagnostic assays for MIF
US5451394A (en) * 1993-08-25 1995-09-19 Isp Van Dyk Inc. Quaternary salts of para-dialkylamino benzamide derivatives
GB9408994D0 (en) * 1994-05-06 1994-06-22 Vanguard Medica Ltd Compounds
US5885974A (en) * 1994-12-06 1999-03-23 Michael M. Danielov Therapeutic methods utilizing naturally derived bio-active complexes and delivery systems therefor
US6238678B1 (en) * 1995-11-06 2001-05-29 The Procter & Gamble Company Methods of regulating skin appearance with vitamin B3 compound
US6492428B1 (en) * 2000-07-26 2002-12-10 The Picower Institute For Medical Research Compounds having MIF antagonist activity
US6420188B1 (en) * 1996-02-16 2002-07-16 The Picower Institute For Medical Research Screening assay for the identification of inhibitors for macrophage migration inhibitory factor
DE19627344A1 (de) * 1996-07-01 1998-01-08 Vitasyn Gmbh Entwicklung & Ver Therapeutisch wirksame bzw. gesundheitsfördernde Zubereitung aus definierten Polyphenolverbindungen
US5998423A (en) 1996-10-08 1999-12-07 Therasys, Inc. Methods for modulating melanin production
US6413939B1 (en) * 1997-10-31 2002-07-02 The Picower Institute For Medical Research Inducible phosphofructokinase and the Warburg effect
US6153177A (en) * 1997-12-15 2000-11-28 Chesebrough-Ponds's Usa, Co., Division Of Conopco, Inc. Skin lightening composition
DE19807774A1 (de) * 1998-02-24 1999-08-26 Beiersdorf Ag Verwendung von Flavonen bzw. Flavanonen bzw. Flavonoiden zum Schutze von Ascorbinsäure und/oder Ascorbylverbindungen gegen Oxidation
US6051602A (en) * 1998-03-16 2000-04-18 The Procter & Gamble Company Methods for regulating skin appearance
US6042841A (en) * 1998-03-16 2000-03-28 Unilever Home & Personal Care Usa Division Of Conopco, Inc. Cosmetic method of treating skin
US20020054895A1 (en) * 1999-07-23 2002-05-09 Alwyn Company, Inc. Allantoin-containing skin cream
US6573050B1 (en) 1999-10-29 2003-06-03 Sunnybrook & Women's College Health Sciences Centre Treatment, diagnosis and evaluation of anti-cancer therapy resistance in melanoma
WO2001032606A1 (en) * 1999-10-29 2001-05-10 The Picower Institute For Medical Research Compounds having mif antagonist activity
FR2804431A1 (fr) * 2000-02-02 2001-08-03 Adir Nouveaux derives heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
GB2348371B (en) * 2000-03-14 2001-04-04 Soares Da Silva Patricio Compositions comprising blockers of L-DOPA renal cell transfer for the treatment of Parkinson's disease
FR2812876B1 (fr) * 2000-08-08 2002-09-27 Galderma Res & Dev Nouveaux composes bi-aromatiques activateurs des recepteurs de type ppar-gamma et leur utilisation dans des compositions cosmetiques ou pharmaceutiques
GB0021182D0 (en) * 2000-08-29 2000-10-18 Unilever Plc Cleaning aid
FR2816502B1 (fr) * 2000-11-10 2003-04-11 Oreal Composition cosmetique comprenant un derive d'aminophenol et un isoflavonoide
FR2818148B1 (fr) * 2000-12-15 2005-06-24 Oreal Composition,notamment cosmetique, renfermant, la 7-hydroxy dhea et/ou la 7-ceto dhea et au moins un isoflavonoide
WO2003039550A1 (en) * 2001-09-20 2003-05-15 Ab Science Use of tyrosine kinase inhibitors for whitening human skin and treating melanocyte dysfunction associated diseases
EP1432420B1 (en) * 2001-10-02 2011-07-13 Acadia Pharmaceuticals Inc. Benzimidazolidinone derivatives as muscarinic agents
US7205107B2 (en) * 2001-12-21 2007-04-17 Cytokine Pharmasciences, Inc. Macrophage migration inhibitory factor (MIF) promoter polymorphism in inflammatory disease
US20030129259A1 (en) * 2001-12-28 2003-07-10 Avon Products, Inc. Topical lightening compostitions and methods of use
WO2003090673A2 (en) * 2002-04-22 2003-11-06 Rtc Research & Development, Llc. Compositions and methods for promoting weight loss, thermogenesis, appetite suppression, lean muscle mass, increasing metabolism and boosting energy levels, and use as a dietary supplement in mammals
GB0216371D0 (en) * 2002-07-13 2002-08-21 Rowett Res Inst The Compounds
US20040081672A1 (en) * 2002-10-25 2004-04-29 Gupta Shyam K. Niacinamide, niacin, and niacin esters based delivery systems for treating topical disorders of skin and skin aging
US6875425B2 (en) 2002-12-12 2005-04-05 Unilever Home & Personal Care Usa Skin lightening agents, compositions and methods
TW200418829A (en) * 2003-02-14 2004-10-01 Avanir Pharmaceutics Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
KR20060054308A (ko) * 2003-07-16 2006-05-22 가부시키가이샤 이야쿠 분지 셋케이 겐쿠쇼 피부 색소침착의 치료제
DE10336883A1 (de) * 2003-08-08 2005-03-10 Basf Ag Kunststoff, insbesondere Polyurethan enthaltend ein sterisch gehindertes, verestertes Amin
CA2548123C (en) * 2003-12-15 2012-05-22 Kuraray Co., Ltd. External preparation for skin
DE102004006144A1 (de) * 2004-02-07 2005-08-25 Merck Patent Gmbh Formulierungshilfsmittel
CN1934080A (zh) * 2004-03-26 2007-03-21 帝斯曼知识产权资产管理有限公司 化妆用芳基烷基酸的氨基酸和肽共轭物
US20070203098A1 (en) * 2004-04-06 2007-08-30 Semafore Pharmaceuticals, Inc. Pten Inhibitors
JP4831454B2 (ja) * 2004-07-02 2011-12-07 独立行政法人産業技術総合研究所 皮膚外用剤
CN101035773B (zh) * 2004-08-10 2012-06-06 詹森药业有限公司 抑制hiv的1,2,4-三嗪-6-酮衍生物
US8357360B2 (en) * 2005-04-23 2013-01-22 E-L Management Corp. Cosmetic compositions containing an aqueous dispersion of silicone elastomers and methods of use
CN101170990B (zh) * 2005-05-03 2012-11-07 荷兰联合利华有限公司 包括共轭亚油酸和烟酰胺的皮肤亮白组合物
ES2390274T3 (es) * 2005-06-04 2012-11-08 Cognis Ip Management Gmbh Microcápsulas
AU2006266025A1 (en) * 2005-06-30 2007-01-11 Purdue Research Foundation Alkenyldiarylmethanes, fused analogs and syntheses thereof
WO2007008541A2 (en) * 2005-07-08 2007-01-18 Kalypsys, Inc. Cellular cholesterol absorption modifiers
DE102006030328A1 (de) * 2005-07-27 2007-02-01 Merck Patent Gmbh Triosen und Tetrosen zur Verstärkung der Wirkung von Hautaufhellern
EP1926490A2 (en) * 2005-09-23 2008-06-04 DSMIP Assets B.V. Use of opioid receptor antagonists
JP5583346B2 (ja) * 2006-01-18 2014-09-03 エルジー ハウスホールド アンド ヘルスケア リミテッド ｃ−Ｋｉｔ活性阻害剤、及び、肌美白剤
US7250158B1 (en) 2006-03-30 2007-07-31 Conopco, Inc. Skin lightening agents, compositions and methods
US7247294B1 (en) 2006-03-30 2007-07-24 Conopco, Inc. Skin lightening agents, compositions and methods
US7270805B1 (en) 2006-03-30 2007-09-18 Conopco, Inc. Skin lightening agents, compositions and methods
WO2007139887A2 (en) * 2006-05-22 2007-12-06 Cargill, Incorporated Methods for treating bone or joint inflammation
DE102006041905A1 (de) * 2006-09-07 2008-03-27 Cognis Ip Management Gmbh Zubereitungen zur oralen Aufnahme (I)
KR100872821B1 (ko) * 2007-08-08 2008-12-09 인하대학교 산학협력단 Ｍｉｔｆ 저해제 및 이를 포함하는 미백용 화장료 조성물
AU2008345225A1 (en) * 2007-12-21 2009-07-09 University Of Rochester Method for altering the lifespan of eukaryotic organisms

Also Published As

Publication number Publication date
JP2012513967A (ja) 2012-06-21
US20100158829A1 (en) 2010-06-24
EP2367522A2 (en) 2011-09-28
MX2011006915A (es) 2011-07-29
WO2010072805A3 (en) 2011-04-28
WO2010072805A2 (en) 2010-07-01

Similar Documents

Publication Publication Date Title
DK3150210T3 (da) Oxidativ fotoaktiveret hudforyngende sammensætning
BRPI0817748A2 (pt) Dispositivo para tratar um osso.
CL2007002837A1 (es) Uso de fenitoina para tratar mucositis oral.
GT200900315A (es) Inhibición de arni de expresión de alfa-enac
BRPI0924431A2 (pt) modelo de anúncio adheat para rede social
BRPI0911714A2 (pt) acessório removível para calçado
ECSP14013171A (es) Composición limpiadora
BRPI0923686A2 (pt) formulações aquosas de siloxano para a produção de espumas de poliuretano macias e frias e altamente elásticas.
BR112012003372A2 (pt) vitamina d3 e análogos da mesma para o tratamento de alopecia.
NI200800334S (es) Un dispositivo para la aplicación de betún líquido para zapatos.
CL2009001363S1 (es) Pieza para maquina de afeitar.
CL2012003624A1 (es) Uso estético de acido cicórico y sus derivados para regular la pigmentacion de la piel; kit para tratar y/o prevenir trastornos de pigmentacion de la piel y/o imperfecciones de la piel.
ECSP10010498A (es) Procesos para la preparación de derivados de heteroarilo benzofusionados
AR106261A1 (es) Una composición para aclarar la piel
CR20110246A (es) Derivados de carbamatos de alquil-heterociclos, su preparación y su aplicación en terapéutica.
CO2019014592A2 (es) Neurotoxina botulínica para el tratamiento de trastornos asociados a la hiperactividad de melanocito y/o exceso de melanina
BRPI0810762A2 (pt) Composição para tratamento da água
CO6361893A2 (es) Método y composición para modulación del color
DK2121142T3 (da) Anvendelse af GDF-5 til forbedring eller vedligeholdelse af hudens udseende
ATE547157T1 (de) Schifell
BRPI0914947A2 (pt) composições para o tratamento de queda de cabelo
FR2946878B1 (fr) Utilisation cosmetique du floridoside comme inhibiteur de la melanogenese.
ECSP109885A (es) Compuestos de cinolina para su uso en el tratamiento de la esquizofrenia
BRPI0912341A2 (pt) produto capaz de ser impesso, e , método para produzir o mesmo.
CR10651A (es) Derivados de feniloxianilina

Legal Events

Date Code Title Description
FA Application withdrawn